<?xml version="1.0" encoding="UTF-8"?>
<p class="p">Pharmaceutical industries are in need of eco-friendly alternatives to drug molecules to treat infectious diseases. Thus, these EOs might be a prospective source of alternative antimicrobial agents and may play an important role in the discovery of new drugs against a wide range of pathogenic microorganisms in the near future.</p>
